Related Experiment Video
Updated: Jul 11, 2025
Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Organ-Specificity of Breast Cancer Metastasis
Marina K Ibragimova1,2,3, Matvey M Tsyganov1,3, Ekaterina A Kravtsova1,2
1Department of Experimental Oncology, Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634009, Russia.
Abstract:
Breast cancer (BC) remains one of the most common malignancies among women worldwide. Breast cancer shows metastatic heterogeneity with priority to different organs, which leads to differences in prognosis and response to therapy among patients. The main targets for metastasis in BC are the bone, lung, liver and brain. The molecular mechanism of BC organ-specificity is still under investigation. In recent years, the appearance of new genomic approaches has led to unprecedented changes in the understanding of breast cancer metastasis organ-specificity and has provided a new platform for the development of more effective therapeutic agents. This review summarises recent data on molecular organ-specific markers of metastasis as the basis of a possible therapeutic approach in order to improve the diagnosis and prognosis of patients with metastatically heterogeneous breast cancer.
Insights
Breast cancer metastasis shows organ-specific patterns, impacting patient outcomes. Understanding molecular markers is key to developing targeted therapies for better breast cancer treatment.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Breast cancer (BC) is a leading cause of cancer worldwide.
- BC exhibits metastatic heterogeneity, with preferential spread to bone, lung, liver, and brain, affecting prognosis.
- The molecular basis for this organ-specificity remains largely unknown.
Purpose of the Study:
- To review recent advancements in understanding the molecular mechanisms of breast cancer metastasis organ-specificity.
- To summarize molecular organ-specific markers of metastasis.
- To explore the therapeutic potential of these markers for improving diagnosis and treatment.
Main Methods:
- Literature review of genomic approaches and molecular studies.
- Analysis of data on organ-specific metastasis in breast cancer.
- Synthesis of information on molecular markers and therapeutic strategies.
Main Results:
- Genomic approaches have significantly advanced the understanding of breast cancer metastasis.
- Identification of molecular markers associated with organ-specific metastasis is ongoing.
- These markers offer a basis for developing targeted therapeutic strategies.
Conclusions:
- Understanding molecular drivers of breast cancer metastasis organ-specificity is crucial.
- Molecular markers hold promise for improving diagnostic and prognostic accuracy.
- Targeted therapies based on these markers could enhance treatment efficacy for metastatic breast cancer patients.
